Venus Remedies shines on registering with DSIR to avail custom duty exemption
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Venus Remedies is currently trading at Rs. 243.10, up by 11.35 points or 4.90% from its previous closing of Rs. 231.75 on the BSE.
The scrip opened at Rs. 240.00 and has touched a high and low of Rs. 243.30 and Rs. 232.50 respectively. So far 6083 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 301.80 on 10-Jul-2023 and a 52 week low of Rs. 145.00 on 08-Feb-2023.
Last one week high and low of the scrip stood at Rs. 246.00 and Rs. 226.15 respectively. The current market cap of the company is Rs. 316.93 crore.
The promoters holding in the company stood at 41.76%, while Institutions and Non-Institutions held 0.98% and 57.26% respectively.
Venus Remedies has made registration with Department of Scientific and Industrial Research (DSIR), Ministry of Science & Technology, Government of India. This significant milestone allows the company to avail custom duty exemption, reinforcing its commitment to innovation, excellence in research, and its substantial contributions to the healthcare sector.
This registration with DSIR exemplifies Venus Remedies' dedication to fostering innovation and making healthcare solutions more accessible. With a strong track record of brining 15 patented products to market and a robust pipeline of innovative pharmaceuticals, the company has consistently demonstrated a forward-thinking approach to drug development.
Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.
